Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 34 EUR 8.63% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Net Margin
Dermapharm Holding SE

7.3%
Current
14%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.3%
=
Net Income
83m
/
Revenue
1.1B

Net Margin Across Competitors

Country DE
Market Cap 1.8B EUR
Net Margin
7%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 746.8B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 365.6B USD
Net Margin
17%
Country US
Market Cap 249.1B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Dermapharm Holding SE.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.3%
=
Net Income
83m
/
Revenue
1.1B
What is the Net Margin of Dermapharm Holding SE?

Based on Dermapharm Holding SE's most recent financial statements, the company has Net Margin of 7.3%.